Klin Farmakol Farm. 2012;26(3):121-122

Personalized medicine

Ondřej Topolčan1, Judita Kinkorová2
1 Centrální izotopová laboratoř, Univerzita Karlova, Lékařská fakulta Plzeň
2 Technologické centrum AV ČR Praha

The work describes the emergence and development of personalized medicine in biomedical research. We discuss the current status of

personalized medicine in Europe, in the world, and in the Czech Republic, and its prospects and perspectives.

Keywords: personalized medicine, genomics, proteomics, European Association for preventive, predictive and personalized medicine

Published: November 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Topolčan O, Kinkorová J. Personalized medicine. Klin Farmakol Farm. 2012;26(3):121-122.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Jain KK. Personalized medicine: the impact of pharmacogenetics on drug development. Decision, Resources, Inc. Walthman MA 1998.
    2. Jain KK. Texbook of Personalized Medicine. Springer 2009. Go to original source...
    3. Jain KK. The handbook of Biomarkers. Springer - Human Press 2010. Go to original source...
    4. Golubnitschaja O. Predictive Diagnostics & Personalized Treatment: Dream or Reality? Nova Science Publishers. New York 2010.
    5. Palička V. Personalizovaná medicína - realita, mýtus, fikce. Cas Lek Cesk 2010; 149(10): 460-461. Go to PubMed...
    6. Höschl C. Nastal čas uplatnění personalizované medicíny v psychiatrii? Prakt Lék 2010; 90(8): 502-505.
    7. Fabián P. Role patologa v prediktivní onkologii solidních nádorů. Cas Lek Cesk 2010; 149(10): 462-463. Go to PubMed...
    8. Campr V. Personalizovaná medicína v hematoonkologii perspektiva patologů. Cas Lek Cesk 2010; 149(10): 464-467. Go to PubMed...
    9. Kvasnička J. Hereditární trombofílie - doporučení pro genetické testování v klinické praxi. Cas Lek Cesk 2010; 149(10): 468-471. Go to PubMed...
    10. Slanař O, Zima T. Farmakogenetické aspekty současné farmakoterapie. Cas Lek Cesk 2010; 149(10): 472-475. Go to PubMed...
    11. Petruželka L. Cílená biologická léčba solidních nádorů. Vnitř Lék 2011; 57: 740-744. Go to PubMed...
    12. Petruželka L. Pohled na vývoj onkologie ve 3. tisíciletí. Klinická onkologie 2009; 22: 11-12. Go to PubMed...

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.